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Background: Tetanus remains common in many low- and middle-
income countries (LMICs) yet the evidence base guiding management 
of this disease is extremely limited, particularly with respect to 
contemporary management options. Sharing knowledge about 
practice may facilitate improvement in outcomes elsewhere. 
Methods: We describe clinical interventions and outcomes of 180 
adult patients ≥16 years-old with tetanus enrolled in prospective 
observational studies at a specialist infectious diseases hospital in 
Southern Vietnam. Patients were treated according to a holistic 
management protocol encompassing wound-care, antitoxin, 
antibiotics, symptom control, airway management, nutrition and de-
escalation criteria. 
Results: Mortality rate in our cohort was 2.8%, with 90 (50%) patients 
requiring mechanical ventilation for a median 16 [IQR 12-24] days. 
Median [IQR] duration of ICU stay was 15 [8-23] days.  Autonomic 
nervous system dysfunction occurred in 45 (25%) patients. Hospital 
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acquired infections occurred in 77 (43%) of patients. 
Conclusion: We report favourable outcomes for patients with tetanus 
in a single centre LMIC ICU, treated according to a holistic protocol. 
Nevertheless, many patients required prolonged intensive care 
support and hospital acquired infections were common.
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Introduction
Tetanus is a vaccine-preventable disease that remains a common 
cause of acute critical illness in low-income and middle-income 
countries (LMICs)1. Signs and symptoms are due to the effects 
of tetanus toxin in the central nervous system and management 
is based on three key strategies: blocking further tetanus toxin 
release2, neutralising unbound toxin3, and alleviating effects of 
already-bound toxin; namely muscle spasms and autonomic 
nervous system dysfunction1,4,5. With access to critical care 
interventions such as mechanical ventilation and advanced 
physiological monitoring, muscle spasms and autonomic nervous 
system dysfunction (ANSD) can be more easily managed6–8. 
These interventions are now available in many LMIC intensive 
care units (ICUs); however, their availability is often not 
associated with improved outcomes9,10.
As almost all tetanus occurs in settings with limited capacity 
for clinical trials, the evidence base for tetanus management 
remains limited. There are few randomized clinical trials to 
support common management strategies and, in the absence 
of high-quality evidence, observational studies and case series 
become the key elements in guiding treatment. The Hospital 
for Tropical Diseases, Ho Chi Minh City, has been a tertiary 
referral centre for tetanus for over 30 years and has developed 
and implemented a specific holistic management protocol for 
patients with tetanus. The ICU continues to admit several 
hundred adult patients with tetanus every year and reports 
outcomes comparable with those from high income settings7,11.
The overall aim of this paper is to pragmatically describe the 
intensive care management of adult tetanus in a LMIC setting 




The Hospital for Tropical Diseases (HTD), Ho Chi Minh 
City is a tertiary referral centre for infectious diseases serving 
Southern Vietnam. Previously the hospital housed a special 
tetanus ICU but whilst this no longer exists, the hospital’s adult 
ICU continues to receive 250-350 adult patients with tetanus 
annually. The principles of tetanus management described 
above have been incorporated into a specific treatment protocol 
(Figure 1), which has been applied consistently to all patients 
over a 10 year period12. In addition to pharmacological 
interventions, the protocol includes directions for airway man-
agement, nutrition and nursing observations. It also includes 
criteria for de-escalation and discharge from hospital.
Participants and data collection
Data on management and outcome of patients treated with 
this protocol were collected from two prospective observa-
tional studies, recruiting two cohorts of patients ≥16 years old 
admitted to the hospital’s ICU with a diagnosis of general-
ized tetanus; the first from August 2016 - March 2017 and 
the second from January - July 2018. For patients enrolled 
between August 2016 and March 2017, additional exclusion cri-
teria were: (i) not speaking Vietnamese, (ii) not being able to 
walk before admission.
Baseline and clinical variables including patient demographic 
details, tetanus severity indicators and management interventions 
and complications were collected prospectively on all enrolled 
subjects. Enrolled patients were followed daily until hospital dis-
charge. Previously described definitions were applied for hospi-
tal acquired infections13. Autonomic nervous system dysfunction 
(ANSD) was defined as at least three of: heart rate >100 beats 
per minute (bpm), systolic blood pressure >140 mmHg, mean 
arterial pressure < 60 mmHg, pyrexia > 38°C, and fluctuating 
blood pressure. All features should be present within one day 
with no other apparent cause14. Sensitivity evaluation of mortality 
rates within this study was performed by comparing with overall 
hospital database for outcomes of all patients with tetanus 
(ICD10 code A35) during the period 2016- 2018.
Statistical analysis
Descriptive statistics were used to describe the sample with the 
median and interquartile range (IQR) for continuous data, and 
count and percentage for categorical data. Due to small num-
bers of those who died, no comparative statistics have been 
performed. All analyses were carried out in Stata (StataCorp) 
version 16. Missing data are included and described in tables.
Ethics statement
This study was approved by the London School of Hygiene and 
Tropical Medicine (LSHTM) ethics committee, the Oxford 
Tropical Medicine Ethics Committee (OxTREC) and the local 
HTD ethics committee (Refs 16904, 596-16, 816 QD-BVBND, 
38-17, 494/ QD – SYT respectively.) All participants gave written 
informed consent to participate before enrolment.
Results
In total, 180 patients with generalised tetanus admitted to 
the ICU at HTD between August 2016 and July 2018 were 
included in this study. During the first period, 80 out of a total 
160 admissions 80 patients were enrolled. For the second 
period, 100 patients were included out of a total of 120 
admissions during that time. Reasons for lower enrolment of the 
first cohort were largely pragmatic due to lack of availability 
          Amendments from Version 1
The revised document includes some clarifications and additions 
in response to the reviewers’ comments. Principally these are 
some clarification in the methods section why the two cohorts of 
patient data were collected from different periods and with some 
differences in entry criteria for the original studies. Secondly, a 
new table (Table 3) has been added to show data about cause 
of death rather than in text. As numbers are very small, no 
comparative hypothesis testing was performed and the table 
contains descriptive data only. A paragraph has been included in 
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of study staff and more stringent enrolment criteria. The median 
[IQR] age of the patients was 51.0 [40.8-61.5]. The young-
est age was 17 and the oldest 98 years old. Of 180 patients, 
73 (40.6%) had at least one comorbidity and 143/180 (79.4%) 
were male. Median Tetanus Severity Score on admission was 
1.5 [IQR -3 – 5], with median time from first symptom to 
admission of 3 [IQR 2-5] days15. Severe tetanus, defined as 
Ablett grade 3 or 4 on hospital admission (i.e. spasms interfer-
ing with respiration with/without autonomic nervous system dys-
function), was diagnosed in 28 patients (16%), but an additional 
66 (37%) progressed to severe disease during hospitalization 
(Table 2). 
A summary of the management and complications of the 
patients during ICU admission are described in Table 1 and 
Table 2.
Description of the cases who died
Of the 5/180 (2.8%) patients that died, 3 deaths were caused by 
cardiogenic shock (occurring at days 2, 12 and 15 of ICU 
Figure 1. Summary of Tetanus Treatment Protocol Hospital for Tropical Diseases, Ho Chi Minh City.
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admission), one death was due to septic shock secondary to 
ventilator associated pneumonia (occurring at day 5 of ICU 
admission) and one was due to ischaemic bowel and perfora-
tion (occurring at day 28 of ICU admission).  A comparison 
of clinical features with those who survived is given in Table 3. 
Review of hospital records showed that in total, during the 
three years 2016–2018, 917 adults were admitted with tetanus 
with an overall case fatality rate of 4% (including palliative 
discharges).
Discussion
We describe clinical features and outcomes of a large cohort 
of patients with tetanus managed at a specialist tetanus centre. 
Patients were managed in accordance with a standardized 
protocol by a team of doctors and nurses with significant 
experience in tetanus management7.
The case fatality rate in this study is 2.8%. This is, to our 
knowledge, the lowest reported mortality rate for a large series 
of tetanus patients worldwide12, and contrasts with rates reported 
from many other LMICs where rates of 45 to 58% have been 
reported despite the availability of mechanical ventilation10,16,17. 
Whilst it is possible that selection bias has influenced our 
results, our figures are similar to official hospital records 
over the study period as well as an observational study 
enrolling patients with severe tetanus from our centre and 
one other major centre in Vietnam between 2013 and 201518. 
We have previously reported a fall in mortality from 28% to 8% 
between 1994 and 2001 as more comprehensive ICU facili-
ties became available20. Comparison with contemporary data 
from other countries is more difficult due to limited reporting 
of established tetanus severity scores or known prognostic fea-
tures. Nevertheless, the age of patients in our study (one of the 
strongest predictors of outcome) is similar to, or even older 
than, those reported in other centres with worse outcomes10,21,22. 
Similarly, our ventilation rate was 50% but rates between 50% 
and 75% elsewhere have been associated with mortality rates 
of 30–35%10,22,23.
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* Ablett score: Grade 1 is mild tetanus with no spasms, Grade 2 mild 
spasms not compromising breathing, Grade 3 is severe tetanus with 
spasms compromising breathing. Ablett Grade 4 is as Grade 3 but with 
additional signs of autonomic nervous system dysfunction19. ** Includes 
those taken home, expected to die.
We report a relatively high rate of hospital acquired infection 
in this cohort, which is similar to those previously observed 
in patients with tetanus. Previous work has indicated that 
these infections are related to length of ICU stay, however 
compared to patients with other diseases, those outcomes 
in patients with tetanus and hospital acquired infections are 
favourable18
We believe that the favourable outcomes at our centre 
result from two major factors: a clear management proto-
col and care by a highly specialized team with enormous 
experience in tetanus. Throughout the world, protocolized 
medical care is encouraged as a means of improving patient 
outcomes. Ideally, protocols are based on best evidence and can 
be regularly updated. However, this is not the case for many of 
the elements of our protocol due to the lack of high-quality 
contemporary evidence for tetanus management. Nevertheless, 
the outcomes in our patients to some extent supports their 
continued use. A limitation of our work is that protocol adher-
ence itself was not specifically measured. Personal experience 
and treatment intervention data reported herein indicate that 
adherence was high; however, we have not specifically examined 
compliance with individual components of the protocol.
Our hospital is a tertiary infectious disease centre and receives 
patients with tetanus from Southern Vietnam. A highly developed 
referral system and limited staff turnover within the ICU means 
that experience in management of tetanus can be more read-
ily easily developed and preserved. Tetanus is a disease where 
progression continues to occur after hospitalization. Experienced 
staff may therefore be better able to anticipate complications, 
and so arrange care and interventions more appropriately. They 
may also be able to pass on subtle elements of care not out-
lined in our protocol – for example exactly when to intervene 
with spasms or how to balance risk of pressure area necrosis 
and spasm provocation when turning a patient. Finally, as a 








Age (years) 79 [64-81] 50 [40-61]
Male sex 5 (100%) 138 (79%)
Comorbidity present 4 (100%) 69 (39%)
Difficulty breathing on admission 5 (100%) 32 (18.3%)
SpO2 on admission (%) 94 [94-97] 97 [95-98]
white blood cell count on admission109/L 16.8 [14.9-23.9] 9.8 [7.4-11.8]
Required mechanical ventilation during hospitalization 5 (100%) 85 (49%)
ANSD during hospitalization 2 (40%) 43 (24.6%)
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that particularly benefited outcomes, such as more careful 
prevention or management of hospital acquired infections which 
are particularly frequent in severe tetanus.
Sharing these forms of tacit knowledge is a challenge for health 
systems across the world but is most likely to benefit lower 
resourced settings with less access to specialised training and 
referral. The current expansion of digital technologies may 
offer possible solutions. For example, newer technologies in the 
form of telemedicine or even AI-enabled risk stratification 
may facilitate dissemination of less explicit knowledge or even 
simplify analysis of these complex processes. 
Additionally, our protocol does not include recommendations 
for physical rehabilitation, although we have previously iden-
tified a cohort of patients with reduced functional outcome 
after hospital discharge20. Understanding what is the most 
appropriate rehabilitation strategy for our context and which 
patients would benefit from this, is a research priority if 
long-term outcomes are to be maximized.
Conclusions
We report management and outcome features in a large 
contemporary cohort of patients with tetanus treated according 
to a standardized protocol. Survival rates of these patients are 
high compared to other reported case series. Nevertheless, 
other outcomes such as duration of hospitalization and mechani-
cal ventilation requirements indicate that tetanus remains a 
significant burden on healthcare services. Therapies that can 
reduce these continue to be needed.
Declarations
Data availability
Oxford University Research Archive. Dataset: Long-term 
outcome in tetanus cohort: 04TS: https://ora.ox.ac.uk/objects/uuid:
af44c622-a7b8-44b2-827e-056623dd49a824.
This project contains the following underlying data:
-       ORA_04TSSF36.xlsx (This is a data set from a clinical 
observation study. The data was manually entered from 
case record forms to a specific database. This dataset is 
from the exported data.)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
Acknowledgements
We would like to thank staff in the adult ICU and Ward D at the 
Hospital for Tropical Diseases.
References
1.  Yen LM, Thwaites CL: Tetanus. Lancet. 2019; 393(10181): 1657–68.  
PubMed Abstract | Publisher Full Text 
2.  Ganesh Kumar AV, Kothari VM, Krishnan A, et al.: Benzathine penicillin, 
metronidazole and benzyl penicillin in the treatment of tetanus: a 
randomized, controlled trial. Ann Trop Med Parasitol. 2004; 98(1): 59–63. 
PubMed Abstract | Publisher Full Text 
3.  Rodrigo C, Fernando D, Rajapakse S: Pharmacological management of 
tetanus: an evidence-based review. Crit Care. 2014; 18(2): 217.  
PubMed Abstract | Publisher Full Text | Free Full Text 
4.  Henriques Filho GT, Lacerda HR, Albuquerque A, et al.: Sympathetic 
overactivity and arrhythmias in tetanus: electrocardiographic analysis. Rev 
Inst Med Trop Sao Paulo. 2007; 49(1): 17–22.  
PubMed Abstract | Publisher Full Text 
5.  Thwaites CL, Yen LM, Loan HT, et al.: Magnesium sulphate for treatment 
of severe tetanus: a randomised controlled trial. Lancet. 2006; 368(9545): 
1436–43.  
PubMed Abstract | Publisher Full Text 
6.  Trieu HT, Lubis IN, Qui PT, et al.: Neonatal tetanus in Vietnam: 
comprehensive intensive care support improves mortality. J Pediatric Infect 
Dis Soc. 2016; 5(2): 227–30.  
PubMed Abstract | Publisher Full Text | Free Full Text 
7.  Thwaites CL, Yen LM, Nga NT, et al.: Impact of improved vaccination 
programme and intensive care facilities on incidence and outcome of 
tetanus in southern Vietnam, 1993-2002. Trans R Soc Trop Med Hyg. 2004; 
98(11): 671–7.  
PubMed Abstract | Publisher Full Text 
8.  Brauner JS, Vieira SR, Bleck TP: Changes in severe accidental tetanus 
mortality in the ICU during two decades in Brazil. Intensive Care Med. 2002; 
28(7): 930–5.  
PubMed Abstract | Publisher Full Text 
9.  Kyu HH, Mumford JE, Stanaway JD, et al.: Mortality from tetanus between 
1990 and 2015: findings from the global burden of disease study 2015. BMC 
Public Health. 2017; 17(1): 179.  
PubMed Abstract | Publisher Full Text | Free Full Text 
10.  da Nóbrega MV, Reis RC, Aguiar IC, et al.: Patients with severe accidental 
tetanus admitted to an intensive care unit in Northeastern Brazil: clinical-
epidemiological profile and risk factors for mortality. Braz J Infect Dis. 2016; 
20(5): 457–61.  
PubMed Abstract | Publisher Full Text 
11.  Thuy DB, Campbell JI, Thanh TT, et al.: Tetanus in Southern Vietnam: Current 
Situation. Am J Trop Med Hyg. 2017; 96(1): 93–96.  
PubMed Abstract | Publisher Full Text | Free Full Text 
12.  An VT, Khue PM, Yen LM, et al.: [Tetanus in Ho Chi Minh City, Vietnam: 
epidemiological, clinical and outcome features of 389 cases at the Hospital 
for Tropical Diseases]. Bull Soc Pathol Exot. 2015; 108(5): 342–8.  
PubMed Abstract | Publisher Full Text 
13.  Loan HT, Yen LM, Kestelyn E, et al.: Intrathecal Immunoglobulin for 
treatment of adult patients with tetanus: A randomized controlled 2x2 
factorial trial [version 2; peer review: 2 approved]. Wellcome Open Res. 2018; 
3: 58.  
PubMed Abstract | Publisher Full Text | Free Full Text 
14.  Duong HTH, Tadesse GA, Nhat PTH, et al.: Heart Rate Variability as an 
Indicator of Autonomic Nervous System Disturbance in Tetanus. Am J Trop 
Med Hyg. 2020; 102(2): 403–407.  
PubMed Abstract | Publisher Full Text | Free Full Text 
15.  Thwaites CL, Yen LM, Glover C, et al.: Predicting the clinical outcome of 
tetanus: the tetanus severity score. Trop Med Int Health. 2006; 11(3): 279–87. 
PubMed Abstract | Publisher Full Text 
16.  Woldeamanuel YW, Andemeskel AT, Kyei K, et al.: Case fatality of adult 
tetanus in Africa: Systematic review and meta-analysis. J Neurol Sci. 2016; 
368: 292–9.  
PubMed Abstract | Publisher Full Text 
17.  Olum S, Eyul J, Lukwiya DO, et al.: Tetanus in a rural low-income intensive 
care unit setting. Brain Commun. 2021; 3(1): fcab013.  
PubMed Abstract | Publisher Full Text | Free Full Text 
18.  Phu VD, Nadjm B, Duy NHA, et al.: Ventilator-associated respiratory infection 
in a resource-restricted setting: Impact and etiology. J Intensive Care. 2017; 
5(1): 69.  
PubMed Abstract | Publisher Full Text | Free Full Text 
19.  Ablett JJ: Tetanus and the anaesthetist; a review of the symptomatology 
Page 7 of 18
Wellcome Open Research 2021, 6:107 Last updated: 07 SEP 2021
and the recent advances in treatment. Br J Anaesth. 1956; 28(6): 258–73. 
PubMed Abstract | Publisher Full Text 
20.  Trung TN, Duoc NVT, Nhat LTH, et al.: Functional outcome and muscle 
wasting in adults with tetanus. Br J Anaesth. 2019; 113(11): 706–13.  
PubMed Abstract | Publisher Full Text | Free Full Text 
21.  Adekanle O, Ayodeji O, Olatunde L: Tetanus in a rural setting of South-Western 
Nigeria: a ten-year retrospective study. Libyan J Med. 2009; 4(2): 78–80.  
PubMed Abstract | Publisher Full Text | Free Full Text 
22.  Aziz R, Colombe S, Mwakisambwe G, et al.: Pre-post effects of a tetanus care 
protocol implementation in a sub-Saharan African intensive care unit. PLoS 
Negl Trop Dis. 2018; 12(8): e0006667.  
PubMed Abstract | Publisher Full Text | Free Full Text 
23.  Tosun S, Batirel A, Oluk AI, et al.: Tetanus in adults: results of the multicenter 
ID-IRI study. Eur J Clin Microbiol Infect Dis. 2017; 36(8): 1455–62.  
PubMed Abstract | Publisher Full Text 
24.  Thwaites L, Duoc NVT, Trung TN: Long-term outcome in tetanus cohort: 
04TS. University of Oxford, 2021.  
http://ora.ox.ac.uk/objects/uuid:af44c622-a7b8-44b2-827e-056623dd49a8
Page 8 of 18
Wellcome Open Research 2021, 6:107 Last updated: 07 SEP 2021
Open Peer Review
Current Peer Review Status:    
Version 2
Reviewer Report 07 September 2021
https://doi.org/10.21956/wellcomeopenres.18786.r45681
© 2021 Vijayaraghavan B. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Bharath Kumar Tirupakuzhi Vijayaraghavan   
Department of Critical Care Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India 
All my comments have now been addressed. I have nothing further to add.  
 
 
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: My clinical and research area of interest is broadly critical care - I also have 
specific experience in the management of critically ill patients with tetanus.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
Reviewer Report 07 September 2021
https://doi.org/10.21956/wellcomeopenres.18786.r45682
© 2021 Bonell A. This is an open access peer review report distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Ana Bonell   
1 MRC Unit The Gambia, London School of Hygiene and Tropical Medicine, Fajara, The Gambia 
2 Centre on Climate Change and Planetary Health, London School of Hygiene and Tropical 
Medicine, London, UK 
I am happy to accept the article as is and have no new comments.
 
 
Page 9 of 18
Wellcome Open Research 2021, 6:107 Last updated: 07 SEP 2021
Competing Interests: No competing interests were disclosed.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
Version 1
Reviewer Report 07 June 2021
https://doi.org/10.21956/wellcomeopenres.18452.r43840
© 2021 Hashmi M. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Madiha Hashmi   
Department of Critical Care Medicine, Ziauddin University, Karachi, Pakistan 
Favorable outcomes of adult patients with generalized tetanus are attributed to consistent, 
holistic, evidence-based and protocolized management by a highly experienced team at a 
specialist infectious diseases hospital in Southern Vietnam that receives 250-350 adult patients 
annually. 
This prospective observational study describes the pragmatic management and outcomes of 180 
patients in two cohorts (August 2016 - March 2017 and January - July 2018) that were followed 
daily till hospital discharge. Factors like age, need for mechanical ventilation (50%), autonomic 
nervous system dysfunction (25%), hospital acquired infections (43%) and median length of ICU 
stay (15 [8-23] days) is comparable to reports from other LMICs but outcome is significantly better 
(2.8% vs. 44% from a Brazilian ICU). 
 
Study Design:
The prospective observational study design describes better outcomes of adult patients 
admitted with generalized tetanus based on a high volume of cases referred to this tertiary 
center and more than 10 years experience of the team rather than adherence to the 
elements of the management protocol. Randomization of patients to either receive a 
bundled care or usual care or studying outcomes based on adherence to the holistic 
protocol will improve the quality of evidence generated. 
 
○
The full exclusion criteria are not mentioned. It is not clear why ALL patients admitted 
during the two study periods were not included in the study and 80 patients (out of 160) in 





To allow others to benefit from their holistic protocols more details of various elements of 
the protocol are needed like recommended timings of antitoxins, antibiotics, tracheostomy 
or mechanical ventilation, details of wound management, targets of nutrition therapy, 
○
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Bharath Kumar Tirupakuzhi Vijayaraghavan   
Department of Critical Care Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India 
Thanks to the authors for this important submission. 
 
Dr Van Hao and colleagues describe their experience and the management of 180 adult patients 
with tetanus from a single-ICU from Southern Vietnam.  As pointed out by the authors, tetanus 
remains a vaccine preventable, but neglected disease in several LMICs. Data on management 
strategies and outcomes from high-performing centers is not only critical for guiding other 
hospitals in the region and from other LMICs, but also in setting the research agenda.  
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I have a few comments for the authors to consider: 
 
Major comments:
Why is there a gap in the study periods? Is this due to the unavailability of data in the 
intervening period? Or is it just a reflection of the fact that the authors use data from two 
readily available prospective cohorts (where information was collected for other reasons)? 
 
A related question is if outcomes varied between the periods as well in the intervening 
period ( I recognize that the overall mortality is low and is perhaps unlikely to be very 
different between periods). 
 
1. 
The outcomes are impressive - is this due to early identification and referral? Could the 




Do the authors have information on intermediate-long term outcomes (survival, QoL, etc.) 
for these patients?  
 
3. 
The authors provide data on nosocomial infections- how do these rates compare to the non-
tetanus intensive care admissions? And how do the outcomes for nosocomial infections 
compare?  Do they have information on the pathogen profile (for instance proportion of 
multidrug resistant organisms)? 
 
4. 
In their treatment protocol, I presume several of the treatments listed are 'OR' options 
rather than 'AND'- for example equine or human antitoxin, diazepam or midazolam etc. Can 
they clarify this in the table so that it is obvious to the readers? 
 
I know this is not listed in their protocol- but are any intrathecal therapies used? 
 
5. 
The section on 'description of cases who died': I agree that numbers are small, but the 
authors could provide the information given in this section as a table comparing 'dead' vs 
'survivors'- they don't have to perform any hypothesis testing.  
 
6. 
Table 2 provides the worst Ablett score during admission- numbers provided in this table do 
not match with those described under the text (in 'Results'). 
 
7. 
In the Discussion section, the authors could briefly highlight what they see as the research 
priorities for tetanus given their experience (for example, need for data on long-term 





Under 'Results': Line 3: Why 160 patients? Shouldn't this be 180? 
 
Line 6: why 100 patients included out of 120- reasons for exclusion of 20? 
 
1. 
Under 'participants and data collection': what is the justification of the additional exclusion 2. 
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criteria (lines 7,8)? Is it just a carryover of the exclusion criteria of the original cohort? 
 
Under 'Discussion': Para 3- the authors say their protocol is 'evidence-based' but then go on 
to also say that most elements don't have much evidence. I know what they mean- but they 
could reframe these sentences.  
 
3. 
The authors note that for a period these patients were managed in a 'special tetanus ICU'- 
are there outcomes from that period? and if yes how do they compare to the later period? 
 
4. 
I note their protocol includes elements around nutrition, discharge criteria, etc. Do they also 
have a plan for physiotherapy or rehab (in the later phases of illness)- these patients require 
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C Louise Thwaites, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam 
Why is there a gap in the study periods? Is this due to the unavailability of data in the intervening 
period? Or is it just a reflection of the fact that the authors use data from two readily available 
prospective cohorts (where information was collected for other reasons)? 
 
The latter is correct. This has been clarified in the text in the methods section. 
 
A related question is if outcomes varied between the periods as well in the intervening period ( I 
recognize that the overall mortality is low and is perhaps unlikely to be very different between 
periods). 
 
We have included the overall death rate of 4% in ALL hospital admissions in the results 
section. This rate includes all the 3 years and all patients (not just those enrolled). As the 
first cohort excluded those who could not walk, and could potentially have excluded the 
most severe group of patients as discussed in the Discussion section. 
  
The outcomes are impressive - is this due to early identification and referral? Could the authors 
comment on this- perhaps provide information on time from symptom onset to admission? 
 
This has been added after the Tetanus Severity Score. 
 
Do the authors have information on intermediate-long term outcomes (survival, QoL, etc.) for 
these patients? 
 
Long-term outcomes are available in the first cohort of these patients and are published 
separately. This has been added and cited again. 
 
The authors provide data on nosocomial infections- how do these rates compare to the non-
tetanus intensive care admissions? And how do the outcomes for nosocomial infections 
compare?  Do they have information on the pathogen profile (for instance proportion of 
multidrug resistant organisms)? 
 
For this study, we have not addressed this specifically. We have in previous studies 
examined and compared rates of nosocomial infections  - as tetanus patients stay for long 
periods of time but have relatively little multi-organ failure compared to other patients with 
similar length of stay, analysis is fairly complex and has not been included here. (See PLoS 
One. 2018 Sep 7;13(9):e0203600) 
 
In their treatment protocol, I presume several of the treatments listed are 'OR' options rather 
than 'AND'- for example equine or human antitoxin, diazepam or midazolam etc. Can they clarify 
this in the table so that it is obvious to the readers? 
 
Thank you – these have been clarified. 
 
I know this is not listed in their protocol- but are any intrathecal therapies used? 
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No these are not currently used. 
  
The section on 'description of cases who died': I agree that numbers are small, but the authors 
could provide the information given in this section as a table comparing 'dead' vs 'survivors'- they 
don't have to perform any hypothesis testing. 
 
This has been done and a table added. 
 
Table 2 provides the worst Ablett score during admission- numbers provided in this table do not 
match with those described under the text (in 'Results'). 
 
The initial results section contains the 28 patients with severe on admission, the table 
contains the number of patients with severe scores (3 or 4) during admission. The text has 
been altered to clarify this. 
 
In the Discussion section, the authors could briefly highlight what they see as the research 
priorities for tetanus given their experience (for example, need for data on long-term outcomes, 
more stringent evaluation of therapies through trials, need for a registry tracking outcomes, etc.) 
 
Minor comments: 
Under 'Results': Line 3: Why 160 patients? Shouldn't this be 180? 
 
This was not clear – 80/160 admissions during the first period were enrolled in this study 
and 100/120 admissions during the second period were enrolled. The text has been 
changed. 
 
Line 6: why 100 patients included out of 120- reasons for exclusion of 20? 
 
 As above. Entry criteria are given in the methods. 
 
Under 'participants and data collection': what is the justification of the additional exclusion 
criteria (lines 7,8)? Is it just a carryover of the exclusion criteria of the original cohort? 
 
 Yes – text has been altered. 
 
Under 'Discussion': Para 3- the authors say their protocol is 'evidence-based' but then go on to 
also say that most elements don't have much evidence. I know what they mean- but they could 
reframe these sentences. 
 
Thank you – we have removed these/ changed to ‘best-available evidence’ 
 
The authors note that for a period these patients were managed in a 'special tetanus ICU'- are 
there outcomes from that period? and if yes how do they compare to the later period? 
 
Yes, we have data – added in the discussion section and cited. 
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I note their protocol includes elements around nutrition, discharge criteria, etc. Do they also have 
a plan for physiotherapy or rehab (in the later phases of illness)- these patients require prolonged 
periods of sedation/paralysis - hence the question. 
 
Currently, these are not written in the protocol but we are aiming to develop these. This has 
been added to the discussion in the ‘priorities’ and future section.  
Competing Interests: No competing interests were disclosed.
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2 Centre on Climate Change and Planetary Health, London School of Hygiene and Tropical 
Medicine, London, UK 
This study presents outcome data for patients with severe tetanus who were treated according to 
a set treatment protocol developed in an intensive care unit in Vietnam. Data was collected from 
2016-2018 and includes 180 patients. Mortality outcomes for this cohort is very low (2.8%) 
compared to other published studies from LMICs. 
 
Thank you for the opportunity to review this study detailing your standardised protocol.  
I have a few minors points for your consideration:
Is it possible to make figure 1 into a flowchart? This would be easier for clinicians to follow. 
Or potentially a checklist like the surgical checklist for example so that clinicians can easily 
see if they have missed any points. 
 
○
Results: In the results section, please check IQR of median age of patients that died and 
check median age – it doesn't look correct. 
 
○
I would like to understand the hospital acquired infection rate in context – how does this 
compare to other conditions on that specific ICU and also compared to other tetanus 
cohorts (43% is high). 
 
○
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Author Response 23 Jun 2021
C Louise Thwaites, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam 
Is it possible to make figure 1 into a flowchart? This would be easier for clinicians to follow. Or 
potentially a checklist like the surgical checklist for example so that clinicians can easily see if they 
have missed any points. 
 
This is a very good suggestion. Currently, the purpose of this piece was to publish in English 
the protocol which is already in use in the Hospital for Tropical Diseases. However, the idea 
to create a flow-chart check list is excellent and we will work on defining the action/stop-
start points. 
 
Results: In the results section, please check IQR of median age of patients that died and check 
median age – it doesn't look correct.~ 
 
This has been checked and now is included in Table 3 
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I would like to understand the hospital acquired infection rate in context – how does this compare 
to other conditions on that specific ICU and also compared to other tetanus cohorts (43% is high). 
 
In this study, we have not specifically looked at that, however previous studies have 
examined this. We have included a discussion around this in the discussion section. 
Essentially what we have found in previous studies is that although rates are high, this is 
generally due to the length of ICU stay and that outcomes are actually relatively good. 
  
In the discussion, please can you add the case fatality rates from other settings for direct 
comparison (e.g. https://pubmed.ncbi.nlm.nih.gov/33824951/)1. 
 
These have been added and the citation above also included.  
Competing Interests: No competing interests were disclosed.
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